Halozyme Therapeutics HALO Property, plant and equipment at cost
Property, plant and equipment at cost at other companies
Other financials
Where this comes from
Reported directly by Halozyme Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.
The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Halozyme Therapeutics's property, plant and equipment at cost.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Halozyme Therapeutics's property, plant and equipment at cost?
- Halozyme Therapeutics (HALO) reported property, plant and equipment at cost of $82.15M in Q1 2026.
- How has Halozyme Therapeutics's property, plant and equipment at cost changed year-over-year?
- Halozyme Therapeutics's property, plant and equipment at cost increased by 21.8% year-over-year, from $67.45M to $82.15M.
- What is the long-term trend for Halozyme Therapeutics's property, plant and equipment at cost?
- Over 5 years (2020 to 2025), Halozyme Therapeutics's property, plant and equipment at cost has grown at a 32.7% compound annual growth rate (CAGR), from $18.88M to $77.6M.